Predominantly defective CD8+ T cell immunity to SARS-CoV-2 mRNA vaccination in lung transplant recipients

By sjmartinez • June 9, 2023

Taus E, Shino MY, Ibarrondo FJ, Hausner MA, Hofmann C, Yang OO. Predominantly defective CD8⁺ T cell immunity to SARS-CoV-2 mRNA vaccination in lung transplant recipients. J Transl Med. 2023 Jun 8;21(1):374. doi: 10.1186/s12967-023-04234-z. PMID: 37291575.

Tags: cellular immunity, COVID-19 mRNA vaccine, Infectious Diseases, Lung transplantation, Publications, Pulmonary, Critical Care & Sleep Medicine, SARS-CoV-2, solid organ transplantation

Multiplex pan-filovirus assay performance and reproducibility across varied geographical and resource settings

Smith OA, Merritt S, Kompany JP, Hoff NA, Wong TAS, Kamara V, Tambu M, Halbrook M, Kindrachuk J, Barrall AL, Musene K, Martin SA, Berestecky[...]

Virus reactivation in acute and long COVID-19

Maguire C, Chen J, Rouphael N, Morse BA, Hoch A, Pickering H, Phan HV, Glascock A, Chu V, Dandekar R; IMPACC Network; Corry D, Kheradmand[...]

Variation in Hospital Visiting Hour Policies in Acute Care Facilities in Four U.S. States: An Exploratory Cross-Sectional Analysis

Garcia CY, Chou C, Caso E, Hudspeth JC, Allan-Blitz LT. Variation in Hospital Visiting Hour Policies in Acute Care Facilities in Four U.S. States: An[...]